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Abstract
Amphotericin B (AmB) is a very effective anti-fungal polyene macrolide antibiotic whose usage is limited by its toxicity. Lack of a
complete understanding of AmB’s molecular mechanism has impeded attempts to design less toxic AmB derivatives. The antibiotic is known
to interact with sterols present in the cell membrane to form ion channels that disrupt membrane function. The slightly higher affinity of AmB
toward ergosterol (dominant sterol in fungal cells) than cholesterol (mammalian sterol) is regarded as the most essential factor on which
antifungal chemotherapy is based. To study these differences at the molecular level, two realistic model membrane channels containing
molecules of AmB, sterol (cholesterol or ergosterol), phospholipid, and water were studied by molecular dynamics (MD) simulations.
Comparative analysis of the simulation data revealed that the sterol type has noticeable effect on the properties of AmB membrane channels.
In addition to having a larger size, the AmB channel in the ergosterol-containing membrane has a more pronounced pattern of intermolecular
hydrogen bonds. The interaction between the antibiotic and ergosterol is more specific than between the antibiotic and cholesterol. These
observed differences suggest that the channel in the ergosterol-containing membrane is more stable and, due to its larger size, would have a
higher ion conductance. These observations are in agreement with experiments.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Amphotericin B (AmB) is a polyene macrolide antibiotic
(Fig. 1a) that has been used as a ‘‘golden’’ standard drug to
treat systemic fungal infections for more than 40 years.
Despite its severe side effects, and particularly its nephrotox-
icity, it is still the drug of choice used to treat advanced
infections due to the lack of better alternatives [1–4]. Sys-
temic fungal infections are often observed as side effects in
chemotherapy treatments which impair the immune system,
and therefore, finding new anti-fungal drugs or improving old
standards is an important emerging problem [4–6]. Unlike
other anti-fungal drugs, AmB does not generate opportunistic
resistance in fungal strains [3]. This desirable property further
enhances AmB’s medical importance. Due to these reasons,
the design of less toxic derivatives or formulations has
important medical implications. Some successful results
concerning lipid or liposome AmB formulations have been
introduced recently (see, e.g., the review in Ref. [7]). How-
ever, such approaches are too expensive for a typical medical
treatment, therefore limiting their usage.
AmB’s molecular mechanism of action is still not under-
stood well enough to make rational design of new deriva-
tives possible. It is known that AmB interacts with the
components of cell membrane and forms ion channels [8–
11]. These ion channels disrupt membrane functions and
cause uncontrolled cation transport through the membrane
that eventually leads to cell death. According to the widely
accepted sterol hypothesis [12,13], presence of sterol mole-
cules in the membrane is necessary for AmB to be able to
form conducting ion channels in cell membranes. It has
been observed that AmB can also form conducting channels
when there are no sterols in the membrane [14]. However,
the level of the antibiotic concentration needed to observe
conductance in these latter channels is much higher than
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required under physiological conditions. Therefore, it is
very unlikely that such channels would be formed under
the physiological in vivo conditions.
Chemotherapeutic application of AmB is based on the
slightly higher (or different) affinity of the antibiotic to-
wards ergosterol-containing membranes (fungal cells) than
cholesterol-containing membranes (animal cells) [13,15,16].
Unfortunately, the affinity of AmB toward cholesterol
molecules is not negligible and this interaction is respon-
sible for the severe toxicity of the antibiotic. There are only
minor structural differences between cholesterol and ergos-
terol (Fig. 1b). Why and how these differences may lead to
higher AmB–ergosterol (AmBEr) than AmB–cholesterol
(AmBCh) affinity were only hypothesized [17,18]. It was
postulated that the molecular structure of ergosterol better
complements that of AmB [19] and that the presence of
additional carbon–carbon double bonds strengthens the
electrostatic interaction between ergosterol and AmB mole-
cules [20,21]. One may also postulate that small structural
differences lead to small differences of interactions between
AmB and sterol molecules. However, since many AmB
molecules are involved in the formation of a single mem-
brane channel, cumulative effect of such small differences
can have a significant influence on the stability of the
channel. The importance of structural features of sterols
for AmB activity is further supported by experiments
showing that AmB-resistant fungal strains contain modified
sterols, which have structures very similar to that of ergos-
terol, in their plasma membrane [3].
It is known that AmB can form two types of channels:
single-length channel (SLC) and double-length channel
(DLC) [22,23]. DLC is simply a channel where two SLC
are arranged in a tail-to-tail configuration. Formation of
DLC channels was observed when the antibiotic is added
from both sides of the membrane. Administering AmB only
from one side of the membrane results in the SLC forma-
tion. In clinical usage AmB is added to the medium in which
the cells are present (i.e., they have access to the cell
membrane only from one side). Therefore, it is reasonable
to assume that SLC-type membrane ion channels are formed
during the regular medical usage. Since it is more relevant,
single-length AmB membrane channel was chosen as the
subject matter of our study.
AmB’s mechanism of action has been studied experimen-
tally for several decades (e.g., Refs. [8–11,15]). Theoretical
studies using various computational chemistry methods were
Fig. 1. (a) Structure of the antibiotic AmB with partial atom numbering. (b) Structure of cholesterol and ergosterol with atom numbering.
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also pursued [19–21,24–34]. Progress in molecular model-
ing methods as well as the developments in computer
technology made it possible to study lipid bilayer and
membrane channel systems at the atomic level (see, e.g.,
recent reviews in Refs. [35–37]). This progress allows for
the use of theoretical studies at the molecular level to
supplement experiments.
The present work is a continuation of our earlier molecu-
lar modeling study of the SLC type AmB-channel in a
cholesterol-containing membrane [32]. In this work we test
the sterol hypothesis that the affinity difference of AmB
towards fungal and animal cells (whose sterol contents are
different) is due to the differences in the interactions between
AmB and the sterols at the molecular level. SLC-type model
AmB membrane channels formed in cholesterol- and ergos-
terol-containing phospholipid bilayers are studied using
molecular dynamics (MD) simulations. Since there is no
experimental evidence that the stoichiometry of the channels
would be different, it is assumed that both channels have the
same AmB–sterol stoichiometry and topology. Because of
these assumptions, it can be expected that the differences
between the properties of the two channels would largely be
due to the differences between AmB’s pattern of interaction
with the sterols cholesterol and ergosterol. As discussed
below, we have observed several noticeable differences
between the channel structures in our modeling study. The
most significant difference is that the diameter of the AmBEr
channel is larger than the AmBCh channel. It was also found
that the AmB channel in the ergosterol-containing membrane
has a more pronounced pattern of intermolecular hydrogen
bonds and that the interaction between AmB and ergosterol
is more specific than the antibiotic’s interaction with choles-
terol. How and why the observed differences can be helpful
in explaining the affinity difference are also discussed.
It is also worth mentioning that our comparative studies of
AmB channels inmembranes containing cholesterol or ergos-
terol can be regarded as a pilot one for future studies of
channels built from other AmB derivatives. According to
biophysical and biological studies of less toxic AmB deriva-
tives, formation of the membrane channels and their stability
are hypothesized as essential factors responsible for better
chemotherapeutic properties of these new AmB derivatives
[38–40].
2. Methods
2.1. Molecular models of studied channels
Even though the molecular structures of AmB and of
cholesterol and ergosterol were determined long time ago
[41–43], the macromolecular structure of the AmB channel
has not yet been obtained experimentally. Nevertheless,
several realistic models of the AmB membrane channel
have been proposed and the predicted properties of these
channels are highly supported by experimental evidences
[8,23,25,27,32,33,44–49]. In these proposed and/or studied
models, which are highly similar, the chain of hydroxyl
groups of AmB (Fig. 1a) faces towards the channel pore,
and the conjugated double bond chains are positioned next
to the membrane sterols and lipids. Such an orientation of
the antibiotic molecules is also supported by recent studies
of the amphipathic/amphiphilic pattern of AmB molecule
[20] and AmB-like isosterical molecules [50].
Our AmB–sterol channel closely resembles the models
suggested earlier by various groups [32]. Each AmB–sterol
channel consists of eight AmB molecules and eight sterol
molecules which are noncovalently associated. The chan-
nels are surrounded by 34 dimyristoylglycerophosphatidyl-
choline (DMPC) (17 in each monolayer) molecules which
represents the model bilayer membrane. This channel/lipid
complex has a cylindrical shape and its both sides, as well as
the interior of the channel pore, are solvated using a total of
1666 water molecules at the bulk water density. We have
studied the same model of AmBCh channel previously
[32,51]. To make the two simulations compatible, the
starting structure of the studied AmBEr channel was cons-
tructed by replacing the cholesterols with ergosterol mole-
cules in the starting structure of AmBCh channel.
2.1.1. AmBCh channel
Being an amphoteric and amphiphatic molecule (Fig. 1a),
AmB forms channels in which its hydrophilic hydroxyl
groups point toward the channel’s pore. Its hydrophobic
part, the chain of conjugated carbon–carbon double bonds,
interacts with surrounding lipids and is buried within the
lipid bilayer. The diameter of the channel is estimated to be
in the 7–10 A˚ range [52]. In the model used in this study,
there are eight molecules each of AmB and the sterols. These
molecules are symmetrically placed around a cylindrical
pore where neighboring AmB molecules form V-shaped
wedges. Sterol molecules occupy these wedges. The phos-
pholipid molecules surround the AmB–sterol complex
forming the membrane bilayer. Details of how the AmBCh
channel was constructed and placed in a pre-equilibrated box
of DMPC phospholipids [53] may be found in Ref. [32]. We
have repeated and extended the MD simulations that were
communicated earlier [32]. In this report we convey the
results of these new simulations. We have started with a
configuration of DMPC molecules which was already equi-
librated [32]. To relieve the stress due to the possible mis-
placements in the starting symmetric structure of AmBCh,
the positions of the DMPC and water molecules were
optimized first using 500 steps of steepest descent followed
by 1000 steps of conjugated gradient methods. AmB and
cholesterol molecules were fixed during this initial optimi-
zation. This AmBCh system was further equilibrated (de-
tailed in Section 2.2) before collecting the simulation data.
2.1.2. AmBEr channel
To form the AmBEr channel, eight cholesterol molecules
in the starting structure of the AmBCh channel were
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replaced with eight ergosterol molecules. This approach
preserved the similarity between the starting structures of
AmBCh and AmBEr channels and allowed for better
comparison of the simulation results. To obtain a physically
relevant initial structure, unphysical structural strains in the
starting configuration of the AmBEr channel was relieved
by geometry optimization using 1000 steps of steepest
descent followed by the 6000 steps of conjugated gradient
methods. During this initial optimization, AmB and ergo-
sterol molecules were fixed and only DMPC and water
molecules were allowed to relax. The channel structure was
later further equilibrated using short MD runs.
2.2. MD simulations
AmBCh and AmBEr simulations were performed in a
very similar manner. All geometry minimization and MD
simulations were performed using the CHARMM molecular
simulation program [54]. The bond, angle, dihedral, van der
Waals, and electrostatic terms were included in defining the
interaction potentials. With the exception of the AmB and
sterols (CHARMM ver. 22), interaction force field parame-
ters were taken from the CHARMM potential library version
25h1 that also contains parameters for lipids [55]. The AmB
and sterol site charges were taken from our earlier study [20]
where partial charges were derived using molecular electro-
static potential fits. The TIP3P model [55,56] was chosen to
represent the water molecules, and its parameters were taken
from CHARMM force field version 25h1.
A group-based cutoff was used to truncate the non-bonded
van der Waals and electrostatic interactions. Each AmB and
sterol was treated as a separate fragment. DMPC molecules
were partitioned into 28 fragments using the CHARMM
program topology-grouping scheme [55]. In the CHARMM
program, group-based truncations are determined using the
distance between the molecular centers of the group. As in
our earlier study [32], a large cutoff distance of 25 A˚ was
used. This large value of cutoff was tested before [32] and
was chosen as necessary to include the interactions between
any two AmB and sterol molecules in the channel. The trun-
cation was implemented using a smoothing switch function
starting from the distance of 22 A˚. The non-bonding inter-
action pair list was updated every 50 steps. The time step was
2 fs. Hydrogen atom covalent bond lengths were restrained
using the SHAKE algorithm with a tolerance of 10 6 A˚.
Constant volume and temperature conditions were used.
To maintain an adequate solvation pattern and to keep the
phospholipid bilayer intact, cylindrical and planar restrains
were imposed on the water molecules and lipids in both
systems. Harmonic mean field restraint potentials as imple-
mented in the CHARMM program were used for this
purpose [57]. An imposed mean field potential with a force
constant of 30 kcal/mol/A˚2 restrained the water molecules
(i.e. water oxygen atoms) to stay inside a symmetrically
placed cylinder with diameter and height of 27 and 54 A˚,
respectively. Similarly, DMPC molecules were restrained
with a force constant of 30 kcal/mol/A˚2 to stay within a
30-A˚ diameter cylinder. No height restraints were necessary
for the lipid molecules.
After the initial energy minimization of the lipid and water
molecule positions, both simulation systems were further
equilibrated in several steps before data collection. The
AmBCh and AmBEr channel systems were first heated to
300j K in 2 ps. Then system in AmBCh was equilibrated for
102 ps. During the first 32 ps of this equilibration, AmB and
cholesterol molecules were constrained to allow for better
equilibration of the somewhat arbitrarily placed water and
DMPC molecules. The equilibration run was continued for
120 ps in the AmBEr simulation. AmB and ergosterol
molecules were constrained during the first 60 ps of this
equilibration. The equilibration stage for AmBEr took longer
because, since its tail chain has one more methyl group,
ergosterol molecules needed more time to relax. The data
collectionMD simulations were run for 250 ps for both cases.
MD trajectory was saved at 0.4-ps intervals for later use;
overall 625 snapshots were recorded for analysis of the
results in each case. Both AmBCh and AmBEr simulations
were performed on a parallel Cray T3E computer. Using 16
nodes, each 250-ps MD simulation took approximately 64
CPU hr.
The time scale of our simulation, 250 ps, is too short to
allow for the observation of major changes, such as the
formation or destruction of the channels or any large
conformational changes such as conversion between the
open and closed channel forms. To observe such changes,
duration of the simulations should be micro- or even milli-
seconds. Unfortunately, the associated costs prohibit such
simulations. However, the time scale of our simulations is
reasonably long enough to investigate the structural proper-
ties of the AmB channels at the microscopic level, and
performed simulations allowed us to find if there are
structural differences that could be responsible for the
presumably higher stability of AmBEr channel than the
AmBCh channel. We would like to note that, to the best of
our knowledge, there is only one published report concern-
ing MD simulation of the phospholipid membrane with
ergosterol [58], and there are no MD studies of AmB
membrane channels where different sterols were used.
Therefore, although it employs somewhat short 250-ps
simulations, this study attempts such comparative investi-
gation for the first time. The experience gained in this study
will be very useful in improving the design of future
simulations with promising AmB derivatives.
3. Results and discussion
The MD simulation trajectories were analyzed to empha-
size the differences in structural and dynamical properties of
AmBCh and AmBEr channels. The analysis focused on
investigating which intermolecular and intramolecular fac-
tors are important for channel’s stability and its functional
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behavior. To have a better understanding of the range of
dynamical motions or structural properties, in addition to
calculating the averages, investigated properties were also
computed for eachmolecule or pair ofmolecules individually.
It should be noted that figures which report single molecule
properties, (Figs. 3, 7, 9 and 10a,b), contain eight plots, one
for each of the eight AmB or sterol molecules in the system.
3.1. Intramolecular properties
3.1.1. Conformation of AmB molecules
The lactone ring of the AmB molecules forming the
channel is quite rigid due to the presence of seven conjugated
carbon–carbon double bonds. As in our previous simulation
[32], only a limited conformational freedom can be observed
for the C6–C7 carbon bond (data not shown). Of the carbon
atoms in this part of the lactone ring, only C6 and C7 do not
have hydroxyl substituents (Fig. 1a); this lack of hydroxyl
substituents allows for the trans–gauche transformation
around the C6–C7 carbon bond. Orientation of the hydroxyl
substituent at C8 is opposite to the orientations of the
substituents at the neighboring carbon atoms. This differ-
ence, and the possibility of having a trans C6–C7 bond,
makes it possible for the hydroxyl at the C8 position to form
intermolecular hydrogen bonds with the hydroxyl groups at
the C5 or the C9 positions of the adjacent AmB molecules.
On the other hand, a gauche C5–C6–C7–C8 conformation
allows for the formation of an: (i) intramolecular hydrogen
Fig. 2. Distribution of /=C42–O41–C19–C18, w=C43–C42–O41–C19 dihedral angles of AmB. Each point corresponds to one snapshot from the MD
trajectory and to one AmB molecule (8 molecules 625 frames = 5000 total data points). Top: AmBCh channel; bottom: AmBEr channel.
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bond between hydroxyl groups at the C5 and C8 atoms, and/
or (ii) intermolecular hydrogen bond between hydroxyl
group at the C5 and C9 atoms of two neighbor AmB
molecules. Based on the observation that the trans–gauche
transformations around the C6–C7 bond are less frequent, it
can be deduced that AmB’s lactone ring is slightly more rigid
in the AmBEr channel. However, in the case of AmBCh
channel, more AmB molecules have the gauche conforma-
tion for C6–C7 bond than in AmBEr channel. It was also
observed that even though the lactone ring is quite restricted,
this ring has some flexibility along the conjugated carbon–
carbon double bonds. Although this heptaenic system is quite
Fig. 3. Change in the cholesterol dihedral angle C17–C20–C22–C23, C20–C22–C23–C24, and C22–C23–C24–C25 as a function of time in the AmBCh
channel. For comparison, bonds C20–C22 and C23–C24 that are adjacent to the carbon–carbon double bond C22–C23 have the trans conformation in the
ergosterol tail chain (data not shown). Each one of the eight lines corresponds to an individual sterol molecule.
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rigid, due to its long length, there is a slight uniform twisting.
This twisting of the double bond chain was observed in both
of the AmB–sterol simulations (data not shown).
The main difference between two channels concerning
the conformational properties of the AmB molecules is in the
fluctuation of u, w dihedral angles, where uuC42–O41–
C19–C18 and wuC43–C42–O41–C19 (Fig. 1a). These
angles determine how the amino-sugar moiety is positioned
with respect to the macrolide’s lactone ring. As was shown
before [32,34], the configurations are largely dominated by
two conformers (Fig. 2): (i) ‘‘open’’ (uc 150j, wc
180j), and (ii) ‘‘closed’’ (uc 60j,wc 180j) forms. In
the ‘‘open’’ conformer, the sugar moiety’s amino and car-
boxyl groups are positioned such that they have the ability to
form intermolecular hydrogen bonds with the complemen-
tary carboxyl and amino groups of the neighboring AmB
molecules. Such interactions allow for the formation of a
hydrogen bond chain at the entrance of the pore and stabilize
the channel [32]. On the other hand, the ‘‘closed’’ confor-
mation is responsible for the formation of intramolecular
hydrogen bonds between the carboxyl and the amino groups.
Since the AmB molecules are not covalently associated, the
‘‘closed’’ conformer does not contribute to channel’s stabi-
lity. A strong correlation between the (u, w) distribution and
the biological activity was observed in our recent molecular
modeling studies of AmB amide derivatives [34]. Distribu-
tion of the (u, w) angles derived from MD trajectories of
both channels (Fig. 2) clearly show that the amino-sugar
moiety has more freedom of movement in the AmBCh
channel. As a consequence, intermolecular hydrogen bonds
between the amino and carboxyl groups may form less
efficiently (with a shorter lifetime) in the case of the AmBCh
channel. In the case of AmBEr channel only two clearly
defined conformes are observed (Fig. 2).
3.1.2. Conformation of sterol molecules
The main structural difference between cholesterol and
ergosterol appears in the hydrophobic tail (Fig. 1b). There-
fore, selected dihedral angles in the tail were monitored.
This analysis confirmed that the rotation around the bonds
adjacent to the C22MC23 double bond in ergosterol is
hindered. The values of the C17–C20–C22–C23 and
C22–C23–C24–C25 angles are 240j and 120j, respec-
tively. Thus, the bonds C20–C22, C22MC23, and C23–
C24 in the tail of ergosterol have trans conformations
throughout the simulation (data not shown). In contrast,
the same tail bonds of cholesterol are not always in trans
conformation (Fig. 3). Therefore, compared to cholesterol’s
tail, ergosterol’s tail chain is stiffer and more elongated. This
difference is particularly obvious when the temporal beha-
vior of the C22–C23 and C23–C24 bonds are analysed.
Fig. 3 shows that during simulation, conformations of the
studied bonds of the cholesterols change often in between
trans and gauche angles. These results are in agreement
with our previous conformational studies of isolated choles-
terol and ergosterol molecules [19]. The rigidity of the
ergosterol tail chain increases its short range van der Waals
contact with the AmB and can contribute to the stability of
the whole channel. These MD results support the hypothesis
that small structural differences between cholesterol and
ergosterol could lead to important differences in AmB–
sterol interactions.
3.1.3. Intramolecular hydrogen bonds
In order to find if there are qualitative differences between
AmBCh and AmBEr channels in their ability to form intra-
molecular hydrogen bonds, the behavior of all eight AmB
molecules was individually tracked. Bonds having all of the
following three features were included in the statistics: (i) the
distance not longer than 3.3 A˚ between donor and acceptor
polar atoms (oxygen or nitrogen), (ii) the distance not longer
than 2.1 A˚ between acceptor polar atom and hydrogen atom,
and (iii) the planar acceptor –hydrogen–donor angle
between 90j and 180j. The statistical distribution of intra-
molecular hydrogen bonds is presented in Fig. 4. Although
there are small differences, the overall shape of intramolec-
ular hydrogen bond distribution is very similar for both
channels. AmBCh channel exhibits only a slightly higher
Fig. 4. Distribution of the total number of AmB intramolecular hydrogen bonds. Each line indicates the percentage of structures (frames) from MD simulation
trajectory having a particular number of hydrogen bonds (indicated on axis X ). AmBCh channel (solid line); AmBEr channel (dashed line).
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number of hydrogen bonds compared to AmB–ergosterol
channel.
3.2. Intermolecular properties
3.2.1. Overall properties of the channel
The most important biophysical feature of the channel is
possibly its pore size. Knowing the pore diameter can be
helpful in deducing if the channel is in its open or closed
state and if it can limit ion passage. The interplay between
AmB diameter and ion passage was analyzed in a previous
study [51]. Since AmB hydroxyl groups point towards the
channel pore and may interact with the passing ions, the
distance between the hydroxyl groups of the AmB mole-
cules oppositely placed across the pore in the narrowest part
of the channel is a good measure of the pore diameter of the
channel. Four such distances were defined by pairing the
eight AmB molecules. The average value of these distances
as a function of time is presented in Fig. 5. The reported
distances are between the hydroxyl groups at AmB’s C3
positions. This level corresponds to the narrowest part of the
channel [29,32]. Comparison of the results indicates that the
Fig. 5. The distance between O3 oxygen atoms of two AmB molecules placed across from each other in the pore. This distance is a reasonable measure of the
pore diameter in the narrowest part of the channel. AmBCh channel (lower dark line); AmBEr channel (upper light line).
Fig. 6. Upper panel: Change of RMSD for AmB (dark line) and cholesterol (light line) molecules as a function of time in the AmBCh channel. Lower panel:
Change of RMSD for AmB (dark line) and ergosterol (light line) molecules as a function of time in the case of AmBEr channel.
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AmBEr channel is slightly wider than the AmBCh channel
(Fig. 5). Since the conductance of the channel is roughly
proportional to the square of the diameter, because of its
larger size, it can be estimated that the ionic conductance
would be higher in the AmBEr channel. The narrower
AmBCh channel may have increased interaction strength
between the AmB molecules, and the hydroxyl groups in the
narrowest part may cause stronger friction effects on the
movement of the ions. It was also found that AmBCh has a
more symmetrical shape. We hypothesize that this differ-
ence is due to different interaction of the channel with
surrounding sterols–cholesterol or ergosterol (see the de-
tailed discussion of these interactions below).
Another property describing the overall behavior of the
channel is the root mean square deviation (RMSD) of the
molecules. The RMSDs as a function of time were calcu-
lated for each AmB and sterol molecule separately and then
averaged for each type of molecules (Fig. 6). The RMSD
values were computed by superimposing the MD snapshot
configurations to the initial symmetric structures of the
AmBCh and AmBEr channels. In the case of the AmBCh
channel, there were some periodic fluctuations, but all AmB
molecules had comparable RMSDs. The RMSD values of
the cholesterol molecules in AmBCh channel were compa-
rable to the RMSD of the AmB molecules. Periodic fluctu-
ations (with cycle times of 25–50 ps) are indicators of
AmBCh channel’s ‘‘breathing’’ motion. These fluctuations
reduce the ‘‘effective diameter’’ of the pore.
On the other hand, the RMSD of the molecules has a
larger variation in the AmBEr channel (data not shown).
Unlike the AmBCh case, there is no observed periodicity in
the RMSD distribution of the AmBEr channel (Fig. 6).
However, close inspection of Fig. 6 shows that the motion
of an AmB molecule and the ergosterol molecules that are in
paired contact with it are correlated. This may indicate that
the ergosterol and AmB molecules pair up better and move
more in concert with each other.
3.2.2. Intermolecular hydrogen bonds between AmB
molecules
Having many polar groups, AmB is prone to form
intermolecular hydrogen bonds. A chain of intermolecular
hydrogen bonds between AmBs in a channel-forming con-
figuration was observed in our previous study using a 60-ps
MD simulation [59]. The results of the 250-ps MD simu-
lation communicated in this report and the results of our
Fig. 7. Number of intermolecular hydrogen bonds formed between amino and carboxyl groups of two neighboring AmB molecules. Each of the eight lines
corresponds to one pair of AmB molecules. AmBCh channel (upper panel); AmBEr channel (lower panel).
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earlier much shorter simulation of the AmBCh channel are
mostly in agreement. The most notable difference is that in
the earlier simulation a chain of intermolecular hydrogen
bonds was observed in the central part of the channel
between the hydroxyl groups of the C8 and C9 sites of
the neighboring AmB molecules [59]. The longer MD
simulation results do not entirely confirm this observation:
The chain of intermolecular hydrogen bonds was observed
only at the beginning of the simulation (data not shown),
and the hydrogen bond chain broke after about 50 ps. In the
AmBEr channel, the chain of intermolecular hydrogen
bonds between the hydroxyl groups of the C8 and C9 sites
did not form at all. The analysis of the MD data also did not
indicate formation of any other stable intermolecular hydro-
gen bond chain in the central part of the channel. However,
it was observed that the C8 and C5 hydroxyl groups form
stable intramolecular hydrogen bonds in both AmBCh and
AmBEr channels (data not shown).
Fig. 8. Distribution of the total number of intermolecular AmB–AmB hydrogen bonds. Each line indicates percentages of structures (frames) from the MD
simulation trajectory having a particular number of hydrogen bonds (x-axis). AmBCh channel (solid line); AmBEr channel (dashed line).
Fig. 9. Number of AmB–sterol hydrogen bonds between the AmB amino group and the closest sterol hydroxyl group as a function of time. Each one of the
eight lines corresponds to a pair of AmB–sterol molecules. AmBCh channel (upper panel); AmBEr channel (lower panel).
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As observed in our previous study [59], a proper con-
formation of the amino-sugar ring allows for the formation of
intermolecular hydrogen bonds between carboxyl and amino
groups of the amino-sugar moieties of neighboring AmB
molecules. Although both AmBCh and AmBEr channels
have this chain of intermolecular hydrogen bonds, their
tendency for forming the bond chain is not the same. In the
AmBEr channel, the intermolecular hydrogen bonds between
amino and carboxyl groups are present on average for seven
out of eight pairs of AmB molecules (Fig. 7). In comparison,
this hydrogen bond chain is much weaker in the AmBCh
channel; at most, four out of eight such bonds are present at
the same time (Fig. 7). This is an important finding because,
since it has a larger pore size, one would expect AmBEr
channel to have less stable intermolecular hydrogen bonds
between the AmB molecules. Apparently, a slightly larger
pore size (as in the AmBEr channel) makes it possible for the
amino and carboxyl groups of the neighboring AmB mole-
cules to couple better and form more steady intermolecular
hydrogen bonds. Since intermolecular hydrogen bonds
between adjacent AmB molecules are essential for channel
stability, one may conclude that AmBEr is more stable. It
should be noted that the amino and carboxyl groups of the
amino-sugar moiety are the usual targets for chemical mod-
ifications of AmB, and the derivatives with bulky substituents
at these positions exhibit very different chemotherapeutic
properties concerning toxicity [34,38,60]. The difference in
the ability to form intermolecular hydrogen bonds that can
stabilize the channel may be responsible for the differences in
the biological properties of the two studied channel types.
The distribution of the total number of intermolecular
hydrogen bonds is presented in Fig. 8. The criteria used
above to define intramolecular hydrogen bonds were also
used in computing the reported intermolecular hydrogen
bond distribution. The distributions for the AmBCh and
AmBEr channels are very similar except that there is a small
Fig. 10. (a) Relative position of cholesterol and AmB molecules in the AmBCh channel as a function of time. Upper panel: Distance between AmB’s C9 carbon
atom and sterol’s C19 carbon atom. Lower panel: Distance between AmB’s C22 carbon atom and sterol C19 carbon. (b) Relative position of ergosterol and
AmB molecules in the AmBEr channel as a function of time. Upper panel: Distance between AmB’s C9 carbon atom and sterol’s C19 carbon atom. Lower
panel: Distance between AmB’s C22 carbon atom and sterol C19 carbon. (c) Distribution of channel structures in the simulation with asymmetric position of
sterol molecule relative to AmB. Number of asymmetric AmB–sterol pairs (out of possible 8) in each MD frame is presented on axis X. Number of snapshots
with a defined asymmetric number of AmB–sterol pairs is presented on axis Y. The AmB–sterol pair was regarded as asymmetric when the distance C9–C19
and C22–C19 differed by more than 2 A˚. AmBCh channel (solid line); AmBEr channel (dashed line).
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shift in the peak position. On average, the AmBEr channel
has a slightly lower number of hydrogen bonds between
AmB molecules. This difference is most likely due to the
difference between the pore size of both channels. Being
slightly smaller, the distance between the AmB molecules
would be shorter in the AmBCh channel. This may help in
the formation of more hydrogen bonds between adjacent
AmB molecules. It has to be kept in mind that the con-
tribution of hydrogen bonds to the stability of the channel
would be proportional to the total number of hydrogen
bonds. Although the AmBCh channel has a larger number
of intermolecular AmB–AmB hydrogen bonds, because of
the slight size difference, it also has less number of other
types of hydrogen bonds than the AmBEr channel. As
reported below, the latter types of hydrogen bonds are more
abundant and dominate the total tally, and therefore, overall
hydrogen bonding contribution to the structural stability is
larger in the AmBEr channel.
Fig. 10 (continued ).
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3.2.3. Intermolecular hydrogen bonds between AmB and
sterol molecules
Two types of hydrogen bonds were postulated to play a
key role in the AmB–sterol interaction [17]: hydrogen bonds
(i) between sterol hydroxyl group and amino group of AmB
molecule, and (ii) between sterol hydroxyl group and car-
boxyl group of AmB molecule. The second type of hydrogen
bond was not detected in either the AmBCh or AmBEr
simulation. The large distance between the sterol’s hydroxyl
and AmB’s carboxyl groups makes it almost impossible to
form a hydrogen bond between these two groups. On the
other hand, intermolecular hydrogen bonds between the
sterol hydroxyl group and the AmB amino group were
detected in both simulations. Although the number of
sterol–AmB hydrogen bonds is not substantial, there are
considerable differences in the AmBCh and AmBEr simu-
lations (Fig. 9). First, there are more hydrogen bonds in case
of the AmBEr channel compared to AmBCh. Secondly, the
distance between the sterol oxygen atom and the AmB
nitrogen atom is almost the same for all pairs of molecules
in the AmBEr channel. This is not the case for the AmBCh
(Fig. 9). We have also monitored the distances between
sterol’s hydroxyl group and AmB’s various groups to inves-
tigate if other hydrogen bonds can be formed between these
molecules. The chemiketal oxygen atom and hydroxyl
groups in the amino-sugar moiety of AmB were traced. It
was found that only a limited number of such bonds is formed
(one to three out of possible eight), and these intermolecular
hydrogen bonds exist only in the case of the AmBEr channel
(data not shown). These results further indicate that the
interaction between cholesterol hydroxyl group and AmB is
less specific than the ergosterol hydroxyl group’s interaction
with the antibiotic.
3.2.4. Relative position of AmB and sterol in the channel
Intermolecular hydrogen bond data presented above show
that the relative position of AmB and sterol is different in
both types of channels. To further investigate the channel
geometry, the following distances between selected carbon
atoms in the rigid parts of AmB and sterol molecules were
also tracked: (i) distance between the C9 carbon atom of
AmB and the C19 carbon atom of sterol (Figs. 1); and (ii)
distance between the C22 carbon atom of AmB and the C19
carbon atom of sterol. Atoms C9 and C22 reside in the
opposite fragments of the AmB lactone ring. The selection
was made in such a way that comparison of both distances
traces the rotation of the sterol’s ring system about its long
axis as well as up and down movement of sterol molecule
relative to AmB molecules. If the C9–C19 and C22–C19
distances are similar, it would mean that the sterol’s ring
system is aligned parallel with the AmB molecules. The
methyl group of the sterol (atom C19) in this case is equally
distant from both chains of AmB lactone ring. The values of
the traced distances for both types of channels are presented
in Fig. 10a–c. In the AmBEr channel, the C9–C19 and
C22–C19 distances are very similar, roughly around 7 A˚, in
seven out of eight molecule pairs (Fig. 10b). In contrast, in
the AmBCh channel only four out of eight pairs have similar
distances, f 8 A˚, between the C9–C19 and C22–C19
atoms (Fig. 10a). When the C9–C19 and C22–C19 dis-
tances differ, the sterol molecules are either rotated along
their long axis (relatively to AmBmolecule) or the alignment
of their long axis with respect to AmB’s position is tilted. It
was also found that for two of the cholesterol molecules in
AmBCh channel the measured distances were around 5 A˚.
These two cholesterol molecules were shifted along the long
axis but, since both measured distances are roughly equal,
they were still parallel to their respective AmB molecules.
Fig. 10c presents the distribution of states (channels) where
position of the cholesterol is rotated using the decision
criteria that C9–C19 and C22–C19 distances differ by more
than 2 A˚. The distributions are roughly the same for both
channels. However, one should remember the case of two
cholesterol molecules in AmBCh channel with shorter traced
distances. Although these molecules are shifted relative to
AmB, they are still positioned parallel to the AmBs. All these
observations indicate that: (i) the relative positioning of
AmB and sterol molecules depends on the sterol type, and
Fig. 11. Distribution of the total number of intermolecular AmB–water hydrogen bonds. Each line indicates the percentage of structures (frames) from the MD
simulation trajectory having a particular number of such hydrogen bonds (x-axis). AmBCh channel (solid line); AmBEr channel (dashed line).
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(ii) the ergosterol ‘‘sticks’’ to AmB better and makes better
molecular contact with AmB than the cholesterol in a
channel configuration. Different relative positioning of ster-
ols and AmBs may also indirectly influence the interaction
between AmB and phospholipid molecules.
3.2.5. Solvation properties of the channel
The distribution of the number of hydrogen bonds
formed between AmB molecules and water molecules is
presented in Fig. 11. The waters in the pore form 13 to 40
hydrogen bonds with the channel forming molecules. The
most noticeable but probably insignificant difference
between the results for the AmBCh and AmBEr channels
is that the distribution of the number of AmB–water hydro-
gen bonds has a slightly more pronounced peak in the
AmBCh channel. This could be indicating that AmBCh
channel has a more steady structure that fluctuates less
over time. In the case of the AmBEr channel, there are
configuration changes that require acquiring new solvation
patterns.
3.2.6. Role of the lipids
The presence of explicit lipid molecules in the simula-
tions was necessary not only to better mimic the membrane
environment but also to find the possible interactions
between AmB or sterols and DMPC molecules. Since only
a relatively thin layer of lipids was used, quantitative study
of the interactions between AmB or sterols and DMPC
molecules would not be reliable. Therefore, we only com-
ment on several interesting observations. The electrostatic
interactions between AmB and lipid molecules can be
important because AmB and DMPC molecules contain
two charged groups each: AmB sugar moiety’s amino
and carboxyl groups, and DMPC phosphate and amino
groups. Since the intramolecular distance between these
two sets of polar groups is roughly equal, formation of a
pair of strong ionic bonds between AmB and DMPC is
possible. Such bonds were observed in both AmB–sterol
channels (Fig. 12), however, these bonds are formed much
more often in the AmBEr channel (based on selected
snapshots from the last 50 ps of the MD simulation). The
observed difference may be due to the tighter interaction
between AmB and ergosterol relative to AmB and choles-
terol. The fact that polar interactions between AmB and
DMPC molecules were observed might be indicating that
lipids play an active role in channel stability, formation,
and destruction.
4. Conclusions
The MD simulations of AmB membrane channels with
two different sterols (cholesterol or ergosterol) in the mem-
brane bilayer revealed that AmB channel properties depend
on the sterol type. Since the simulations differ only in the
molecular structures of the sterols, the differences in the
results can be assumed to be mainly due to the differences in
the interactions between AmB and sterol molecules. Noting
that the AmB membrane channel is a supramolecular com-
plex, it would not be surprising if small variations in local
interactions can give rise to important differences in the
overall properties.
Fig. 12. A snapshot of the AmBCh channel (upper panel), and a snapshot of
the AmBEr channel (lower panel). Both snapshots are the last frames of the
respective MD simulations. AmB and sterol molecules are presented as
balls, DMPC molecules as sticks. Sterol molecules are yellow. Black arrows
present the accounted AmB–DMPC interactions if the distance between the
AmB’s amino nitrogen (blue) and DMPC’s phosphate (pink) atom or
between the DMPC’s amino nitrogen (blue) and AmB’s carboxyl oxygen
(red) atom is less than 4 A˚.
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The main differences between AmBCh and AmBEr
channels observed during MD simulations can be summar-
ized as follows:
– The diameter of the AmBEr channel is larger than that of
the AmBCh channel. Since channels are very similar in
character, larger pore size implies more efficient trans-
mission of the ions.
– Mutual placement of sterol and AmB molecules is
different in the AmBCh and AmBEr channels. Ergoster-
ols in the AmBEr channel make better contact with the
antibiotic molecules and they are more likely to move in
accord with AmB molecules than cholesterols. This
allows for more favorable van der Waals interactions
between ergosterol and AmB molecules. In contrast,
cholesterol molecules are more free to move independ-
ently and are able to slide up or down along AmB. Such
independent movements often break the possible short-
range van der Waals interactions between cholesterol and
AmB molecules in the AmBCh channel.
– Intermolecular hydrogen bonds between amino and
carboxyl groups of neighboring AmB molecules are
formed more efficiently in the AmBEr channel.
– Formation of intermolecular hydrogen bonds between
sterol’s hydroxyl group and AmB amino group is more
pronounced in the AmBEr channel.
– Interactions between DMPC polar groups and AmB
amino or carboxyl groups are more pronounced in the
AmBEr channel.
Because of the observations listed above, our MD simu-
lation results support the expectation that the AmBEr chan-
nel is more stable than the AmBCh channel. These
observations are consistent with sterol hypothesis of selec-
tive toxicity of AmB, and also support the experimental
efforts leading to obtain new sterically hindered derivatives
synthesized by modifying the amino group of AmB’s amino-
sugar moiety (e.g., Refs. [38,60]). These new derivatives
bear large substituents at the amino group site, and they are
particularly designed to block the intermolecular hydrogen
bond ring formed at the pore entrance. Breaking of the
hydrogen bond network modifies AmB and sterol mole-
cules’ freedom of movement and, as a result, can have a
strong impact on the short range interactions due to the
molecular contact [17]. As implied in our simulation results,
having better contact between AmB and sterols is important
in increasing the stability of the membrane ion channel. As a
consequence, the changes in the channel structure affecting
the AmB’s molecular contact with the sterols could be
defining the toxicity of AmB’s derivatives.
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